Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome


Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment. 

EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.


EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.


Don’t know what the exposome is?

Want to know more about exposure-related immune diseases?

Curious to know more about what to expect from this project?

Latest news

New EXIMIOUS SOP tool for biological samples published

The EXIMIOUS project has released a new Standard Operating Procedures (SOP) tool as part of their toolbox to standardise the collection, storage, and shipment of biological samples for analysing internal exposome markers. The EXIMIOUS project, which gathers extensive data to study exposome markers, operates across diverse sites such as mines, factories, and hospitals. This complexity

Read More »

‘Internal effect markers’ – Take-aways from the 6th EXIMIOUS Symposium

The sixth EXIMIOUS Symposium was held online Thursday, 7 March 2024, attracting around 40 participants. This edition, titled “Internal effect markers: immune, genetics and epigenetics”, zoomed in on the topic of the impacts environmental and occupational exposures have on our health through three talks by the invited experts Dr. Unni Cecilie Nygaard (Norwegian Institute of

Read More »

Project facts

EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.

Stay social!

We are active with a dedicated project account across several social media channels.

Join our community and stay up to date on all the latest EXIMIOUS news and exposome-related topics.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.